BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10652320)

  • 1. Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding.
    Rezaie AR
    J Biol Chem; 2000 Feb; 275(5):3320-7. PubMed ID: 10652320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding exosite of factor Xa.
    Rezaie AR
    Trends Cardiovasc Med; 2000 Nov; 10(8):333-8. PubMed ID: 11369259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the heparin binding exosite of factor IXa.
    Yang L; Manithody C; Rezaie AR
    J Biol Chem; 2002 Dec; 277(52):50756-60. PubMed ID: 12397068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the alpha-helix 163-170 in factor Xa catalytic activity.
    Levigne S; Thiec F; Cherel G; Irving JA; Fribourg C; Christophe OD
    J Biol Chem; 2007 Oct; 282(43):31569-79. PubMed ID: 17726015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa.
    Rezaie AR
    J Biol Chem; 1998 Jul; 273(27):16824-7. PubMed ID: 9642241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ixolaris: a factor Xa heparin-binding exosite inhibitor.
    Monteiro RQ; Rezaie AR; Ribeiro JM; Francischetti IM
    Biochem J; 2005 May; 387(Pt 3):871-7. PubMed ID: 15617517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.
    Gale AJ; Yegneswaran S; Xu X; Pellequer JL; Griffin JH
    J Biol Chem; 2007 Jul; 282(30):21848-55. PubMed ID: 17553804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of a factor Va binding site in factor Xa.
    Rudolph AE; Porche-Sorbet R; Miletich JP
    J Biol Chem; 2001 Feb; 276(7):5123-8. PubMed ID: 11087737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.
    Rezaie AR; Manithody C; Yang L
    J Biol Chem; 2005 Sep; 280(38):32722-8. PubMed ID: 16079143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor Va alters the conformation of the Na+-binding loop of factor Xa in the prothrombinase complex.
    Yang L; Manithody C; Qureshi SH; Rezaie AR
    Biochemistry; 2008 Jun; 47(22):5976-85. PubMed ID: 18457426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
    Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; MourĂ£o PA
    Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
    Izaguirre G; Aguila S; Qi L; Swanson R; Roth R; Rezaie AR; Gettins PG; Olson ST
    J Biol Chem; 2014 Dec; 289(49):34049-64. PubMed ID: 25331949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of basic residues of the autolysis loop in the catalytic function of factor Xa.
    Manithody C; Yang L; Rezaie AR
    Biochemistry; 2002 May; 41(21):6780-8. PubMed ID: 12022882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional mapping of charged residues of the 82-116 sequence in factor Xa: evidence that lysine 96 is a factor Va independent recognition site for prothrombin in the prothrombinase complex.
    Manithody C; Rezaie AR
    Biochemistry; 2005 Aug; 44(30):10063-70. PubMed ID: 16042383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of the 185-189-loop in the factor Xa interaction with Na+ and factor Va in the prothrombinase complex.
    Rezaie AR; Kittur FS
    J Biol Chem; 2004 Nov; 279(46):48262-9. PubMed ID: 15347660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.
    Rezaie AR; Yang L; Manithody C
    Biochemistry; 2004 Mar; 43(10):2898-905. PubMed ID: 15005625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of the mechanism underlying acceleration of the interaction between antithrombin and factor Xa by heparin pentasaccharide.
    Quinsey NS; Whisstock JC; Le Bonniec B; Louvain V; Bottomley SP; Pike RN
    J Biol Chem; 2002 May; 277(18):15971-8. PubMed ID: 11854268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.
    Majumder R; Koklic T; Rezaie AR; Lentz BR
    Biochemistry; 2013 Jan; 52(1):143-51. PubMed ID: 23214401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentasaccharide enhances the inactivation of factor Xa by antithrombin by promoting the assembly of a Michaelis-type intermediate complex. Demonstration by rapid kinetic, surface plasmon resonance, and competitive binding studies.
    Rezaie AR
    Biochemistry; 2006 Apr; 45(16):5324-9. PubMed ID: 16618121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.
    Yang L; Ding Q; Huang X; Olson ST; Rezaie AR
    Biochemistry; 2012 May; 51(19):4078-85. PubMed ID: 22540147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.